Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diffuse Cutaneous Aphthosis After Combined Targeted Cancer Therapies and Responsive to Pentoxifylline.

Autor: Larocca CA; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Fay CJ; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Hirner JP; Department of Dermatology, University of Missouri Health Care, Columbia., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee., LeBoeuf NR; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2023 Oct 01; Vol. 159 (10), pp. 1136-1139.

Digital Database of Absorption Spectra of Diverse Flavonoids Enables Structural Comparisons and Quantitative Evaluations.

Autor: Taniguchi M; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204, United States., LaRocca CA; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204, United States., Bernat JD; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204, United States., Lindsey JS; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204, United States.

Publikováno v: Journal of natural products [J Nat Prod] 2023 Apr 28; Vol. 86 (4), pp. 1087-1119. Date of Electronic Publication: 2023 Feb 27.

An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions.

Autor: Larocca CA; Department of Dermatology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA, USA., Silk AW; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Kaufman HL; Division of Surgical Oncology, Massachusetts General Hospital, 55 Fruit Street, Warren 408C, Boston, MA, 02114, USA. HLKaufman@mgh.harvard.edu.

Publikováno v: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Dec; Vol. 21 (6), pp. 821-832.

Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

Autor: Yan G; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Eller MS; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA., Elm C; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA., Larocca CA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ryu B; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA., Panova IP; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA., Dancy BM; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bowers EM; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Meyers D; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lareau L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Cole PA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: pcole@jhmi.edu., Taverna SD; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: staverna@jhmi.edu., Alani RM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: alani@bu.edu.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2013 Oct; Vol. 133 (10), pp. 2444-2452. Date of Electronic Publication: 2013 Apr 18.